Tonix Pharmaceuticals Holdin

Biotech Stocks Healthcare Stocks

$12.76

+0.01 (+0.08%)

As of Jun 30, 10:24 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +219.3% upside

Low Target $28.14

Average Target $40.74

High Target $50.62

Current Price $12.76

Current
$12.76

Target
$40.74

$28.14 $40.74 avg $50.62

Scenario Analysis

Bear Case

$28.14

120.5%

Low target

Base Case

$40.74

+219.3%

Avg target

Bull Case

$50.62

+296.7%

High target

Risk/Reward

2.5x

Favorable

Price in Context

52-Week High

$69.97

-81.8% from high

52-Week Low

$10.03

+27.2% from low

Target vs 52W High

$40.74

-41.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%